newsAbbott’s Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy…
7 July 2020 | By Hannah Balfour (European Pharmaceutical Review)
Abbott’s Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices are given approval.